Boston, MA–February 27, 2017: On Thursday, March 9 at the Boston Colonnade Hotel, over 225 top-tier leaders in life sciences will convene to discuss and brainstorm key topics that are challenging business development in the biopharma industry. BD Boston is an off-the-record forum for leading life science C-suite executives, decision- makers, entrepreneurs, venture capitalists, buysiders, corporate venture firms, and healthcare investors.
BD Boston is focused on partnerships, deal-making and business development within biotech and biopharma. The agenda will address industry-relevant challenges facing top executives; when to think commercial; forging innovative partnerships, placing the patient at the center of the business model; how to build a robust pipeline, where are tomorrow’s drugs coming from; partnering with cell & gene therapy companies; funding; life after the deal; managing shareholders expectations; and more.
“BD Boston continues to be a must-attend meeting for the world’s leading pharmaceutical and biotechnology companies discussing in an off-the-record manner deal making and investment in the life sciences,” said Bob Oliver, President & CEO, Otsuka Pharmaceuticals.
Richard Brudnick-SVP, Corporate Development, Biogen
Mike Crowley-Global Head Innovation Partnering, Roche
Doug Giordano-SVP, Worldwide BD, Pfizer
Philippe Lopes-Fernandes-SVP, Global Head of BD & Alliance Management, EMD Serono Ivana Magovcevic-Liebisch, SVP & Head of Global BD, Teva
Bob Oliver-President & CEO, Otsuka Pharmaceuticals
Sanjiv Patel-EVP, Chief Strategy Officer, Allergan
Michal Preminger-Executive Director, Harvard University
Jigar Raythata-CBO, Jounce Therapeutics
Catherine Sohn-Chairman, ConcentRx
Pascal Touchon-Global Head Oncology Strategy & BD, Novartis
Chris Viehbacher-Managing Partner, Gurnet Point Capital
The BD Boston Deal of the Year Award will be presented at the close of the meeting prior to closing cocktails and hors d’oeuvres.
BD Boston is sponsored by L.E.K., Purdue Pharma, JBK Associates International, Mundipharma and the BioPharma Executive Council.
ABOUT BOSTON BIOTECH CONFERENCES
The Boston Biotech Conferences (BBC) mission is to build a vibrant community of biopharma leaders, which will help to drive innovation in biotech by convening leaders across industry and academia. The conferences are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co- hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community. These off-the-record forums bring together the past, present and future leaders in the healthcare community to network, exchange ideas and share insights into the industry’s challenges and opportunities. BBC calendar of events at: http://bbbiotechconference.com/conferences.php
For more information, view agenda or register: http://bbbiotechconference.com/conference-agenda.php?id=55
Contact: Michelle Lifton, Boston Biotech Conferences, email@example.com